- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01818388
COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest (COOL-ARREST)
June 25, 2018 updated by: ZOLL Circulation, Inc., USA
A Multicenter, Prospective, Single Arm Observational Trial to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest
A multicenter prospective single arm interventional trial in hospitals where therapeutic hypothermia is standard practice.
This trial will enroll 50 subjects to evaluate the ability of the ZOLL Intravascular Temperature Management (IVTM) System to induce, maintain, and reverse mild therapeutic hypothermia and maintain normothermia post cardiac arrest.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
New Britain, Connecticut, United States, 06050
- The Hospital of Central Connecticut
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Wayne State University / Detriot Medical Center
-
Royal Oak, Michigan, United States, 48073
- William Beaumont Hospital
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55407
- Minneapolis Heart Institute Foundation
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth Hitchcock Medical Center
-
-
South Carolina
-
Columbia, South Carolina, United States, 29203
- Palmetto Health Clinical Trials Department
-
Greenville, South Carolina, United States, 29605
- Greenville Hospital System
-
-
Tennessee
-
Chattanooga, Tennessee, United States, 37403
- Chattanooga Center for Neurologic Research
-
-
Texas
-
Houston, Texas, United States, 77030
- University of Texas Health Science Center at Houston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Subjects that have experienced an out-of-hospital cardiac arrest.
Description
Inclusion criteria:
- Signed informed consent
- 18 years of age or older
Out-of-hospital witnessed cardiac arrest with any rhythm [Ventricular Fibrillation/Tachycardia (VF/VT), Pulseless Electrical Activity (PEA), or Asystole (AS)] during EMS phase of treatment
OR:
Out-of-hospital unwitnessed cardiac arrest with VF upon EMS arrival
- Lack of meaningful response to verbal commands upon arrival to hospital after suffering non-traumatic cardiac arrest in an out-of-hospital setting
- Return of spontaneous circulation (ROSC) within 30 minutes of EMS arrival
- Able to maintain a SBP > 90mmHg for 30 minutes post ROSC without the use of pressors OR with stable dose of pressors (if escalation of pressors is required, patient is not eligible)
- Undergoing Therapeutic Hypothermia using ZOLL's IVTM System within twelve hours of ROSC BUT should have been initiated as soon as possible
Exclusion Criteria
- Traumatic cardiac arrest [due to blunt trauma, penetrating injury (e.g., stabbing, gunshot, etc.), burns, exsanguinations, strangulation, smoke inhalation, electrocution, hanging, drowning, etc.]
- Toxicological etiology (e.g., inhalation of toxic substances, drugs, etc.)
- Known or suspected pregnancy
- Do Not Attempt to Resuscitate (DNAR) order in force
- Ward of the state or prisoner
- Anatomy, previous surgery or disease state contraindicating femoral venous access
- Received neuromuscular blocking agents or central nervous system sedatives whose effects have not worn off prior to assessing level of consciousness following ROSC
- Hypothermia initiated at a transferring facility prior to arrival at the enrolling hospital (excludes pre-hospital IV fluids or cold packs for cooling by EMS)
- Current Inferior Vena Cava (IVC) filter
- Known history of acute neurological illness or severe functional disabilities prior to arrest (e.g., seizures, traumatic brain injury, increased intracranial pressures, intracerebral hemorrhage, etc.)
- Known heparin allergy
- Known allergy to any adjunctive pharmacologic agent required for induction or maintenance of therapeutic hypothermia
- Known history of bleeding or blood disorders such as coagulopathy, cryoglobulinemia, sickle cell or thrombocytopenia with a platelet count below 40,000.
- Known hypersensitivity to hypothermia including a history of Raynaud's disease
- Evidence of intracranial bleed
- Terminal illness or life expectancy of less than 3 months prior to arrest
- Currently enrolled in another investigational drug or device trial that has not completed the primary endpoint or that clinically interferes with this trial's endpoints Note: For the purpose of this protocol, subjects involved in extended follow-up trials for products that were investigational but are currently commercially available are not considered enrolled in an investigational trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
IVTM system, therapeutic hypothermia
Induced therapeutic hypothermia post cardiac arrest
|
Induced therapeutic hypothermia post cardiac arrest.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Proportion of subjects in which IVTM can therapeutically cool patients as a measure of Performance
Time Frame: Day 1
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Ability to Enroll Subjects, Proportion of those Enrolled that Complete the Study Protocol and Time to complete Enrollment of 50 Subjects Defined as Retention
Time Frame: Up to 90 days
|
Up to 90 days
|
Incident Adverse Events Defined as Safety
Time Frame: Up to 90 days
|
Up to 90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Brian O'Neil, MD, Wayne State University, School of Medicine Specialist and Chief, Detroit Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2014
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
February 4, 2013
First Submitted That Met QC Criteria
March 21, 2013
First Posted (Estimate)
March 26, 2013
Study Record Updates
Last Update Posted (Actual)
June 26, 2018
Last Update Submitted That Met QC Criteria
June 25, 2018
Last Verified
April 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EDC-1978
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Out of Hospital Cardiac Arrest
-
Medical University of ViennaLudwig Boltzmann Institute Digital Health and Patient Safety; Emergency Medical...RecruitingCardiac Arrest, Out-Of-HospitalAustria
-
University Medical Centre MariborOHK Medical DevicesRecruiting"The Effect of the Use of an Autotransfusion Device on Hemodynamic Parameters During Resuscitation".Cardiac Arrest | Out of Hospital Cardiac ArrestSlovenia
-
National Taiwan University HospitalRecruitingOut-Of-Hospital Cardiac ArrestTaiwan
-
Far Eastern Memorial HospitalRecruitingOut-Of-Hospital Cardiac ArrestTaiwan
-
King's College LondonKing's College Hospital NHS Trust; London Ambulance Service NHS TrustNot yet recruiting
-
Wroclaw Medical UniversityWroclaw Emergency Medical ServicesRecruiting
-
Sunnybrook Health Sciences CentrePrescott-Russell Paramedic Service; Peterborough Paramedic Service; Bruce County... and other collaboratorsRecruiting
-
Emergency Medical Services, Capital Region, DenmarkTrygFonden, Denmark; Danish Heart Foundation; Zoll Medical CorporationRecruitingOut-Of-Hospital Cardiac ArrestDenmark
-
Guy's and St Thomas' NHS Foundation TrustLondon School of Hygiene and Tropical Medicine; King's College London; King's... and other collaboratorsActive, not recruitingOut-Of-Hospital Cardiac ArrestUnited Kingdom
-
National Taiwan University HospitalCompletedOut-Of-Hospital Cardiac ArrestTaiwan
Clinical Trials on ZOLL Intravascular Temperature Management System (IVTM)
-
ZOLL Circulation, Inc., USAAsahi Kasei Medical Co., Ltd.Completed
-
The University of Texas Health Science Center,...Zoll Medical Corporation; Vivian L. Smith Foundation for Neurologic ResearchTerminatedSubdural Hematoma, TraumaticUnited States, Japan
-
jiaoliqunRecruitingIschemic Stroke | Reperfusion Injury | Hypothermia | ThrombectomyChina
-
ZOLL Circulation, Inc., USAUnknown
-
Zoll Medical CorporationWithdrawnCardiac Event | Cardiac Disease | STEMI | Heart Attack | Cardiac Infarct | NSTEMI
-
C. R. BardBoston University; Yale UniversityTerminatedIschemic Stroke | Fever | Subarachnoid Hemorrhage | Intracerebral HemorrhageKorea, Republic of, United States, Germany, Switzerland, Austria, Australia
-
Dynatherm Medical Inc.UnknownGeneral Anesthesia | Orthopedic SurgeryUnited States
-
University of Erlangen-Nürnberg Medical SchoolTerminatedAcute Ischemic StrokeGermany
-
Peking University First HospitalPeking UniversityNot yet recruitingDelirium | Hypothermia | Long-term Survivors | Cancer SurgeryChina
-
University of Maryland, BaltimoreWithdrawnRespiratory Distress Syndrome, Adult | Sars-CoV2United States